Delaware Medical Cannabis Foundational Certification

$160.00

The Medical Cannabis Foundational Certification will allow you to learn the core fundamentals of cannabis science and explore cannabis industry knowledge, so you are prepared to be a certified in your state. Our courses and certifications will provide you with knowledge and skillset to enter the cannabis job market competitively, right out of the gate. This certification is not just for medical professionals, but for budtenders who want to enroll in the most robust cannabis certification course as your educational foundation.

As you expand your cannabis educational pursuits, make sure to check out additional courses such as our Advanced CBD Certification. Medical Marijuana 411 will be adding new expert level certifications monthly. Subscribe to our e-news to stay informed!

Since 2009, we’ve been committed to equipping the cannabis industry with top-notch knowledge. Chances are, many of your proficient employees have already benefited from our programs!

If you want to talk about how to train your entire team or have additional questions,  please call us at 844-411-0500 or email at help@mm411.com.

Learn From The Leader In Global Medical Cannabis Education

Add To Cart

Does your state have legal cannabis?

Yes!  Medical Cannabis is legal in Delaware a law took effect on July 1, 2011, and some favorable revisions have been made since then. The Delaware Medical Marijuana Act (Title 16 Ch. 49 A), which is largely based on the Marijuana Policy Project’s model bill, removes criminal sanctions and provides protection from arrest for the compassionate, doctor-recommended use of medical marijuana by Delaware patients with serious medical conditions.

What does the Certification Include?

The Medical Cannabis Foundational Certification will allow you to learn the core fundamentals of cannabis science and explore cannabis industry knowledge, so you are prepared to be a certified in your state. Our courses and certifications will provide you with knowledge and skillset to enter the cannabis job market competitively, right out of the gate. This certification is not just for medical professionals, but for budtenders who want to enroll in the most robust cannabis certification course as your educational foundation.

As you expand your cannabis educational pursuits, make sure to check out additional courses such as our Advanced CBD Certification. Medical Marijuana 411 will be adding new expert level certifications monthly. Subscribe to our e-news to stay informed!

The Medical Cannabis Foundational Course is an online course that covers a series of 12 modules designed to teach healthcare and industry professionals the fundamental topics of cannabis and includes a specific module on the legal framework, forms and other pertinent information regarding the Delaware Medical Marijuana program.

In addition to Delaware specific regulations,  learn about the federal legal framework of working with medical marijuana patients, the basics of the cannabis plant, the Endocannabinoid System, and how cannabinoid receptors work with our bodies. Additional modules will cover important topics like: how to medicate, inhalation versus ingestion, contraindications, drug-on-drug interactions, and recommended rations of specific illnesses.

Did you know?  Healthcare Professionals are covered by Federal Law to talk to patients about Medical Marijuana even in non-legal states by an existing statute? That’s the wealth of information contained in MM411, Inc. certifications.

This certification also  includes: video testimonials from scientists and medical experts, downloadable infographics, additional visuals to support the written content followed by an exam to receive your certificate. Any individual wanting to learn more about the science of cannabis will find the course valuable. And we guarantee your complete satisfaction or your money back. To date, MM411, Inc has never had a return. Enrollees love our certifications and we stand by our courses with a 100% guarantee.

If you are a dispensary, medical group, or company and interested in multi-seat pricing or a customized, white label course, please call 844.411.0500.

The Delaware Medical Marijuana Act (Title 16 Ch. 49 A), which is largely based on the Marijuana Policy Project’s model bill, removes criminal sanctions and provides protection from arrest for the compassionate, doctor-recommended use of medical marijuana by Delaware patients with serious medical conditions. The law took effect on July 1, 2011

Patients are not allowed to grow their own medicine, but they may possess up to six ounces of marijuana. The program includes tightly regulated, limited distribution of medical marijuana by not-for-profit compassion centers. Currently, six compassion centers are operating in the state.

Allowing medical use: To qualify to use medical cannabis, the patient’s physician must have certified, in writing, that the patient has a specified debilitating medical condition and that the patient would receive therapeutic benefit from medical marijuana. Patients then must send the Delaware Department of Health and Social Services (DHSS) a completed application (obtained from DHSS), including a copy of the written certification, and DHSS will issue an ID card after verifying the information. As long as the patient is in compliance with the law and in possession of an ID card, there will be no arrest.

The mission of the Office of Medical Marijuana (OMM) is to protect Delawareans  through proactive monitoring and enforcement of the Delaware Medical Marijuana  Act and accompanying regulations. Rigorous inspection of the regulated vendors  minimizes the risk to human health and environmental impact. OMM accomplishes  this mission by:

  • Working with the regulated vendors to ensure safe and effective products are available to Delaware’s registered patients
  • Stringent control of product inventory to eliminate diversion and use of Medical Marijuana products by non-patients
  • Briefing the medical community on their protections and limitations involving the Medical Marijuana Program
  • Involving state and local community leaders in discussions pertinent to issues affecting communities
  • Close coordination with state and local law enforcement on concerns dealing with the Compassion Centers
  • Responsiveness to Delaware’s registered patients

The Division of Public Health (DPH), authorized by 16 Del.C.Ch.49A – Delaware’s Medical Marijuana Act, regulates the state’s Medical Marijuana Program (MMP). As an applicant to the Medical Marijuana Program you are responsible for reading this act and following the stipulations within it. For a complete copy of the Delaware Medical Marijuana Act, contact the DPH Office of Medical Marijuana, or download it here.

  • Qualifying Conditions ·  Cancer
  • Terminal Illness
  • Positive status for Human Immunodeficiency Virus (HIV Positive)
  • Acquired Immune Deficiency Syndrome (AIDS)
  • Decompensated Cirrhosis
  • Amyotrophic Lateral Sclerosis (ALS/Lou Gehrig’s Disease)
  • Agitation of Alzheimer’s Disease
  • Post-Traumatic Stress Disorder (PTSD)
  • Autism with aggressive behavior
  • Glaucoma
  • Chronic Debilitating Migraine
  • Anxiety (CBD Rich Card Only)
  • A chronic or debilitating disease or medical condition or its treatment that produces one or more of the following;
    1. Cachexia or Wasting Syndrome
    2. Severe debilitating pain that has not responded to previously prescribed medication or surgical measure for more than three months, or for which other treatment options produced serious side effects.
    3. Intractable Nausea
    4. Seizures
    5. Severe and persistent muscle spasms, including but not limited to those characteristic of Multiple Sclerosis.

Can other medical conditions be added to the list?

  • Any citizen may petition the Department to add conditions or treatments to the list of debilitating medical conditions. This is accomplished by petitioning the Department for consideration of an illness. Click here for petition information.

I have one of the debilitating medical conditions, am I automatically a qualified patient?

  • Official written certification must be obtained from a Delaware licensed health care practitioner and submitted with the application.

Course Syllabus

Module 1 – US Legal

  • U.S. Controlled Substances Act
  • Drug Schedule – Cannabis Schedule I
  • Drug Schedule (Graphic)
  • COVID Cannabis Guidelines
  • Economic Impact
  • Cannabis genus of flowering plants in the family Cannabaceae
  • Legal differentiation between hemp and marijuana distinguished by their respective concentrations of the cannabinoid delta-9 tetrahydrocannabinol (THC)
  • 2018 Farm Bill
    • Impact on hemp classification
  • SAFE Banking Act
  • U.S. Pat. No. 6,630,507
  • Trademarks
  • Ogden Memo
  • Cole Memo
  • Wilkenson Memo
  • 2018 Sessions Memorandum
  • Rohrabacher–Blumenauer Amendment
  • Joyce Amendment
  • Conant v. Walters
  • What Medical Professionals Can Legally Provide To Their Patients (Graphic)
  • Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research
  • Guidance for Industry – Downloadable PDf
  • Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research
  • Guidance for Industry – Video Explainer
  • Taxes
  • Affirmative Defense
  • Bankruptcy Protection
  • Employment Law
  • Access to Banking  – Financial Crimes Enforcement Network FinCEN Guidance
  • Copyright and Registration

Module 2 – Delaware Cannabis Legal Module

Module 3 – History

  • Early History of Cannabis Use
  • Cannabis in the West
  • U.S. Prohibition History
  • The Medical Implications of U.S. Prohibition
  • Medical Cannabis Today
  • Hemp vs Cannabis
  • Brief Chronology of History in Spain and throughout Europe

Module 4 – The Discovery of the Endocannabinoid System

  • Introduction of the Endocannabinoid System (ECS)
  • Largest Receptor System
  • ECS – Video Explainer
  • Newly Discovered
  • Chemical Bridge to All Bodily Functions
  • Homeostasis
  • Healthy Body = Healthy ECS
  • ECS – Downloadable Graphic
  • Dr Jake Felice – What is the Endocannabinoid System (ECS)? Video Interview
  • Largest Neurotransmitter System of all “the body’s supercomputer”
  • 1964 discovery of THC and CBD – Raphael Mechoulam, Ph.D and Yehiel Gaoni, Ph.D
  • The Scientist – video regarding Raphael Mechoulam, Ph.D discoveries
  • Allyn Howlett, Ph.D  – Isolating THC in the brain – 1998
    • No cannabinoid receptors in the cardiac and respiratory centers of the brainstem therefore no overdose from cannabis
  • Raphael Mechoulam, Ph.D found in 1992, brain chemical that mirrors the effects of THC
    • Two brain chemicals – anandamide, Sanskrit word “ananda” brain chemical that mimics THC and CBD, 2-Arachidonoylglycerol, which they named 2-AG.
  • Endogenous Molecules “endocannabinoids”.
  • CB1 receptors, and CB2 receptors
  • Cannabinoids and how they attach to receptors
  • CB1 receptors
    • Located in the central nervous system and affect many brain functions including movement, anxiety, stress, fear, pain, appetite, reward, and motor control
  • CB2 receptors
    • CB2 receptors control the release of cytokines, immuno-regulatory proteins, that are linked to inflammation during illness or after injury.
  • Retrograde Inhibition
  • Lack of education on the Endocannabinoid System
  • Clinical Studies
  • At a Glance – Downloadable Infographic
  • Homeostatsis
  • Human Thriving Behavior and the ECS

Module 5 – One Plant, One Complex Chemical Factory

  • Minor Cannabinoids: CBG CBC CBN THCV
  • Terpenes
  • The Entourage Effect & Tolerance / ECS Down Regulation
  • Botanical vs. Single Molecule Compounds & Cannabinoids and Opioids

Module 6 – Getting Cannabinoids into the Bloodstream

  • Inhalation: Smoking vs. Vaporization
  • In the News Discussions
  • Cannabis Flower vs. Concentrate
  • Different Concentrate Consistencies
  • Extraction Methods
  • Winterization
  • Concentrates Using Solvents
  • Solventless Concentrates
  • Edibles, Oral Mucosal, Topicals and Suppositories
  • The Role of the Medical Provider
  • The Role of the Dispensary: Experts within the Dispensary

Module 7 – Patient Centered Dosing

  • Considerations Before Medicating with Cannabis
  • Set and Setting
  • Drug-Drug Interactions
  • Relative Contraindications
  • Youth Under 25
  • Patients and Cardiac Conditions
  • Patients with Psychiatric Diagnoses
  • Immunocompromised Patents
  • Biphasic Effect
  • Finding the Appropriate Dose
  • Recommended Ratios for Specific Illnesses

 Module 8 – Laboratory Testing

  • How Testing Works
  • Contaminants: Pesticides, Fungi and Mold
  • How to Interpret a Test

Module 9 – Clinical Practice

  • Anxiety Disorders
  • Cancer
  • Epilepsy
  • Gastrointestinal Disorders
  • Glaucoma
  • HIV/AIDS
  • Migraine Headaches
  • Multiple Sclerosis
  • Neurodegenerative Disorders
  • Neuropathy
  • Pain
  • Palliative Care
  • Parkinson’s Disease
  • Post Traumatic Stress Disorders
  • Sleep Disorders
  • Traumatic Brain Injury (TBI)
  • Endometriosis
  • Premenstrual Syndrome and Premenstrual Dysphoric Disorder
  • Menopause

Module 10 – Cannabis and Opioids

  • Pain Management Today
  • Cannabis and Opioids: The Good News
  • Cannabis and NSAIDS: More Good News

Module 11 – Medical Myths and Facts

  • Gateway Theory, Addiction and Brain Function
  • Impaired Motivation, Memory and Mental State
  • Lung Damage, Usage Patterns and Overall Danger

Module 12 – Side Effects Abuse and Misuse

  • Cannabinoid Hyperemesis Syndrome
  • Cannabis Use Disorder (CUD)
  • Short and Long Term Side Effects
  • Physical and Mental Effects
  • Cannabis and driving
  • Cannabis Overconsumption and Tolerance

Cited Experts

With over 800+ current, peer reviewed citations, Medical Marijuana 411 is proud to be the global leader in online medical marijuana education for patients, medical professionals and cannabis dispensary consultants.

View all of our Cited Experts

Additional videos from leading cited cannabis experts, scientists and physicians, and downloadable graphics are part of this certification. Here is a partial list of the scientists, researchers, educators and lawyers whose work is cited within the Medical Marijuana 411 certifications.

Our goal of creating the most current content for this cannabis certification course was obtained by using peer-reviewed research from industry experts. All citations utilized in this course meet standard guidelines and are part of the public domain. Experts listed below are not affiliated with Medical Marijuana 411 and no endorsement or authorization should be inferred by their inclusion on our website. Medical Marijuana 411 has included links to each expert to ensure credit is given for their research, legal and scientific studies under the guidelines of “Fair Use.”